Skip to main content

Peer Review reports

From: Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre

Original Submission
11 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Jan 2023 Reviewed Reviewer Report - Stephen P. Ackland
7 Mar 2023 Reviewed Reviewer Report
3 Apr 2023 Author responded Author comments - Naureen Starling
Resubmission - Version 3
3 Apr 2023 Submitted Manuscript version 3
5 Apr 2023 Author responded Author comments - Naureen Starling
Resubmission - Version 4
5 Apr 2023 Submitted Manuscript version 4
8 Apr 2023 Author responded Author comments - Naureen Starling
Resubmission - Version 5
8 Apr 2023 Submitted Manuscript version 5
Publishing
17 Apr 2023 Editorially accepted
26 Apr 2023 Article published 10.1186/s12885-023-10857-8

You can find further information about peer review here.

Back to article page